This episode features Dr. Gurmeet Sran, Chief Clinical Data Science Officer at Dignity Health. Here, he discusses his path to Dignity Health, what the newer role of Chief Clinical Data Science Officer ...
As part of conversations between AI healthcare leaders on the podcast AI Amplified this year, a clear picture emerged of where artificial intelligence is genuinely transforming healthcare — and where ...
In today’s ACT Brief, we examine why fragmented data systems continue to slow life sciences research, review how sponsor ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...
The clinical research landscape is rapidly transforming. Instead of viewing patients as subjects, sponsors now use the patients’ input to help reduce the burden they face during trials. This ...
The field of clinical sciences encompasses every facet of patient‐centred medicine, from bedside diagnosis and therapeutic decision‐making to the integration of cutting‐edge technology in routine ...
Adaptive workflow systems represent a significant departure from rigid, process-centric approaches. Instead of imposing a linear, step-by-step structure, teams will be able to dynamically assign and ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
As we step into 2026, the AI and analytics story for health care and life sciences isn't about sudden disruption -- it's about a steady, strategic evolution toward smart, practical innovation. The ...
-- Low-dose povetacicept (80 mg administered once every four weeks) was well tolerated during subcutaneous administration and reduced UPCR by greater than 50% in IgA nephropathy -- -- Higher dose ...